Answers are grounded in this paper and cite their sources.
Background Sinonasal malignant lymphoma accounts for approximately 1% of head and neck malignancies, and necrosis often precludes diagnosis on a single biopsy.Aims/Objectives To determine the first-biopsy diagnostic rate by site of origin, histologic subtype, and biopsy method, and to describe the modifications made at repeat biopsy in non-diagnostic cases.Material and Methods We retrospectively reviewed 24 patients with sinonasal malignant lymphoma at a single university hospital (2014–2024; median age 68.5 years; 15 men, 9 women).Results Subtypes were diffuse large B-cell lymphoma (DLBCL; 12), extranodal NK/T-cell lymphoma (ENKL; 8), MALT lymphoma (2), and others (2); sites were the nasal cavity (12) and maxillary (6), ethmoid (5), and sphenoid (1) sinuses. The overall first-biopsy diagnostic rate was 70.8% (17/24): 75.0% for DLBCL (9/12) and ENKL (6/8), 83.3% (10/12) for the nasal cavity, and 58.3% (7/12) for the paranasal sinuses (p = 0.371). Five of seven non-diagnostic cases involved the paranasal sinuses, with only non-specific inflammation and necrosis.Conclusions and Significance Approximately 30% of cases were not diagnosed at the first biopsy, mostly paranasal sinus lesions. Although site differences were not significant, clinicians should anticipate repeat biopsy for paranasal sinus lesions; general anesthesia may be considered when adequate sampling is difficult under local anesthesia.
No takes yet. Share an insight, caveat, or question.
Takemiya et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: